- Home
- Publications
- Publication Search
- Publication Details
Title
CCR9 in cancer: oncogenic role and therapeutic targeting
Authors
Keywords
CCR9, CCL25, Biomarker, Chemoresistance, Metastasis, Targeting therapy
Journal
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-16
DOI
10.1186/s13045-016-0236-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes
- (2015) N. Khandelwal et al. EMBO Molecular Medicine
- Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment
- (2015) Aiko Koga et al. JOURNAL OF DERMATOLOGY
- Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells
- (2015) Dongmei Fan et al. Journal of Hematology & Oncology
- Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia
- (2015) Jingjing Wu et al. Journal of Hematology & Oncology
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- Intracellular expression profile and clinical significance of the CCR9–CCL25 chemokine receptor complex in nasopharyngeal carcinoma
- (2015) L-F Ye et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway
- (2015) Baijun Li et al. MEDICAL ONCOLOGY
- CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist
- (2015) Sangjun Lee et al. Molecular Oncology
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
- (2015) Pranav Gupta et al. Oncotarget
- Cardiovascular drug delivery with ultrasound and microbubbles
- (2014) Evan Unger et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunotoxins for leukemia
- (2014) A. S. Wayne et al. BLOOD
- Bridging cancer biology and the patients' needs with nanotechnology-based approaches
- (2014) Nuno A. Fonseca et al. CANCER TREATMENT REVIEWS
- Strong expression of chemokine receptor CCR9 in diffuse large B-cell lymphoma and follicular lymphoma strongly correlates with gastrointestinal involvement
- (2014) Winnie Wu et al. HUMAN PATHOLOGY
- Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model
- (2014) Hossein Panjideh et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
- (2014) Yi Yu et al. Journal of Hematology & Oncology
- Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma
- (2014) Debra Ehrlich et al. Journal of Hematology & Oncology
- Strategies for modern biomarker and drug development in oncology
- (2014) Alan D Smith et al. Journal of Hematology & Oncology
- New antibody approaches to lymphoma therapy
- (2014) Tejas Suresh et al. Journal of Hematology & Oncology
- A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
- (2014) Caroline S Breton et al. Journal of Hematology & Oncology
- An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies
- (2014) Tapan K. Bera et al. LEUKEMIA RESEARCH
- Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
- (2014) Sonia Chamorro et al. mAbs
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
- (2013) Polina Weitzenfeld et al. CANCER LETTERS
- Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma
- (2013) Beatriz Somovilla-Crespo et al. Journal of Hematology & Oncology
- Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25
- (2013) Li Zhang et al. PLoS One
- Immunotoxins: The Role of the Toxin
- (2013) Antonella Antignani et al. Toxins
- Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
- (2012) Laura Kühnelt-Leddihn et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
- (2012) M. R. Kuhne et al. CLINICAL CANCER RESEARCH
- Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
- (2012) Huanhuan Joyce Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of chemokine receptors on circulating tumor cells in patients with solid tumors
- (2012) Alberto Fusi et al. Journal of Translational Medicine
- Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma
- (2012) Alexander JA Deutsch et al. MODERN PATHOLOGY
- A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity
- (2012) J. E. Weldon et al. MOLECULAR CANCER THERAPEUTICS
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemokines in tumor development and progression
- (2011) Naofumi Mukaida et al. EXPERIMENTAL CELL RESEARCH
- Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia
- (2011) Leonardo Mirandola et al. JOURNAL OF PATHOLOGY
- Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin
- (2011) Yi Hu et al. LEUKEMIA RESEARCH
- CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion
- (2011) Crystal Johnson-Holiday et al. World Journal of Surgical Oncology
- The Mechanism of Chemokine Receptor 9 Internalization Triggered by Interleukin 2 and Interleukin 4
- (2010) Xiaoling Tong et al. Cellular & Molecular Immunology
- Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells
- (2010) Yun Wang et al. Cellular & Molecular Immunology
- Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
- (2010) T. Ishii et al. CLINICAL CANCER RESEARCH
- CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide
- (2010) Praveen K. Sharma et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25
- (2010) Li Zhang et al. LEUKEMIA RESEARCH
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion
- (2010) Erica L Johnson et al. World Journal of Surgical Oncology
- CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion
- (2010) Erica L Johnson et al. Journal of Ovarian Research
- Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis
- (2009) Julio E. Valdivia-Silva et al. CANCER LETTERS
- Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma
- (2009) Armin Rehm et al. INTERNATIONAL JOURNAL OF CANCER
- CC Chemokine Receptor 9 Enhances Proliferation in Pancreatic Intraepithelial Neoplasia and Pancreatic Cancer Cells
- (2009) Xiaoming Shen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9
- (2009) Beibei Zhou et al. LEUKEMIA RESEARCH
- Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine
- (2008) F. F. Amersi et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now